Clinical Implications of Determining BMPR2 Mutation Status in a Large Cohort of Children and Adults With Pulmonary Arterial Hypertension
- 10 April 2008
- journal article
- Published by Elsevier
- Vol. 27 (6) , 668-674
- https://doi.org/10.1016/j.healun.2008.02.009
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Management of Pulmonary Arterial Hypertension With a Focus on Combination TherapiesThe Journal of Heart and Lung Transplantation, 2007
- Quality of Life in Pulmonary Arterial Hypertension: Improvement and Maintenance With BosentanThe Journal of Heart and Lung Transplantation, 2007
- Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial HypertensionCirculation, 2005
- Outcomes in Children With Idiopathic Pulmonary Arterial HypertensionCirculation, 2004
- Primary Pulmonary Hypertension Is Associated With Reduced Pulmonary Vascular Expression of Type II Bone Morphogenetic Protein ReceptorCirculation, 2002
- Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta familyJournal of Medical Genetics, 2000
- Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertensionNature Genetics, 2000
- Familial Primary Pulmonary Hypertension (Gene PPH1) Is Caused by Mutations in the Bone Morphogenetic Protein Receptor–II GeneAmerican Journal of Human Genetics, 2000
- Vasodilator Therapy for Primary Pulmonary Hypertension in ChildrenCirculation, 1999
- The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary HypertensionNew England Journal of Medicine, 1992